Canagliflozin vs Trastuzumab

## Canagliflozin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Trastuzumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Trastuzumab — 28 days.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Trastuzumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Trastuzumab — N/A.

**Type**: Canagliflozin — Small molecule; Trastuzumab — Antibody.